KYMERA THERAPEUTICS, INC. (KYMR) Operating cash flow 2019–2025
KYMERA THERAPEUTICS, INC. (KYMR) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$232.9MFY2025 · since FY2019: $17.9M → -$232.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$232.9M | -19.7% |
| FY2024 | -$194.5M | -89.2% |
| FY2023 | -$102.8M | +32.8% |
| FY2022 | -$153.1M | -18.7% |
| FY2021 | -$128.9M | -246.3% |
| FY2020 | $88.1M | +392.2% |
| FY2019 | $17.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice